These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [TBL] [Abstract][Full Text] [Related]
5. Patient satisfaction with an informed consent process. Agre P; McKee K; Gargon N; Kurtz RC Cancer Pract; 1997; 5(3):162-7. PubMed ID: 9171552 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and carboplatin: a phase I study in advanced non-small cell lung cancer. Paccagnella A; Favaretto A; Oniga F; Ossana L Semin Oncol; 1996 Dec; 23(6 Suppl 16):76-9. PubMed ID: 9007128 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy for resectable non-small cell lung cancer. Finkelstein EJ; Urschel JD; Takita H J Exp Clin Cancer Res; 1997 Dec; 16(4):437-9. PubMed ID: 9505221 [TBL] [Abstract][Full Text] [Related]
8. A case of informed consent obtained from a patient with terminal cancer and his family using family function by the primary care physician. Tsuboi K; Minegishi Y; Harada T; Ishizaki F; Nitta K Hiroshima J Med Sci; 2007 Jun; 56(1-2):11-8. PubMed ID: 17760268 [TBL] [Abstract][Full Text] [Related]
9. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330 [TBL] [Abstract][Full Text] [Related]
10. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC). Cohen RB; Langer CJ; Simon GR; Eisenberg PD; Hainsworth JD; Madajewicz S; Cosgriff TM; Pierce K; Xu H; Liau K; Healey D Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646 [TBL] [Abstract][Full Text] [Related]
11. A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer. Vokes EE; Figlin R; Hochster H; Lotze M; Rybak ME Cancer J Sci Am; 1998; 4(1):46-51. PubMed ID: 9467046 [TBL] [Abstract][Full Text] [Related]
12. [Recent topics in chemotherapy for elderly patients with lung cancer]. Okamoto H; Watanabe K Gan To Kagaku Ryoho; 2000 Jul; 27(8):1097-104. PubMed ID: 10945002 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group. Huber RM; Flentje M; Schmidt M; Pöllinger B; Gosse H; Willner J; Ulm K; J Clin Oncol; 2006 Sep; 24(27):4397-404. PubMed ID: 16983107 [TBL] [Abstract][Full Text] [Related]
14. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233 [TBL] [Abstract][Full Text] [Related]
15. Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial. Akerley W; Choy H; Safran H; Sikov W; Rege V; Sambandam S; Wittels E Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-10-S12-13. PubMed ID: 9331112 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial. Greco FA; Hainsworth JD Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-14-S12-17. PubMed ID: 9331113 [TBL] [Abstract][Full Text] [Related]
17. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633 [TBL] [Abstract][Full Text] [Related]
18. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study. Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138 [TBL] [Abstract][Full Text] [Related]
19. [Drug therapy in bronchial carcinoma]. Manegold C; Drings P Schweiz Med Wochenschr; 1995 Jul; 125(29):1396-405. PubMed ID: 7545824 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial. Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]